Global /United States /Healthcare /Medical Care Facilities /BICX
chevron_leftBack
BioCorRx Inc. logo

BioCorRx Inc.

BICX
OTCMKTS: BICX Delayed
0.2433USD 0%
As of 13 June 2026, BioCorRx Inc. has a market cap of $11.58M USD, ranking #40466 globally and #5259 in the United States. It ranks #3600 in the Healthcare sector, and #433 in the Medical Care Facilities industry.
Global Rank
40466
Country Rank
5259
Sector Rank
3600
Industry Rank
433
Key Stats
Market Cap
$11.58MUSD
Enterprise Value
$13.3MUSD
Revenue (TTM)
$797.24KUSD
EBITDA (TTM)
-$4.79MUSD
Net Income (TTM)
-$3.44MUSD
PS Ratio
14.5
PB Ratio
-1.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Lourdes Felix open_in_new
Employees
3
Founded
2009
Website
biocorrx.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% -40% -39% -36% -39% -15%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
BICX
BioCorRx Inc
ISIN: US09073C2052
Shares Out.:
29.056M1 Shares Float: 18.743M2
TV:
SA:
YF:
GF:
BA:
MS:
0.2433 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About BioCorRx Inc.

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company offers a substance use disorder recovery program, Beat Addiction Recovery, which includes cognitive behavioral therapy modules, peer support through a mobile application, and medication prescription from an independent treating physician; and the UnCraveRx weight loss program, a medication-assisted weight loss program that includes access to concierge on-demand wellness specialists. It also develops BICX101, an injectable and implantable naltrexone product; BICX102, a long-acting naltrexone implant that can last several months for opioid dependence and alcohol use disorders; and BICX104, a biodegradable, long-acting subcutaneous pellet of naltrexone for the treatment of alcohol and opioid use disorder. The company licenses and distributes its program to healthcare providers and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. was founded in 2009 and is based in Anaheim, California.

Similar Companies

Industry: Medical Care Facilities (United States)
Name
Market Cap diff.
PE
$96.73B
835K%
14.9
$21.13B
182K%
24.6
$15.78B
136K%
11.6
SOLV
$11.53B
99K%
7.5
ENSG
$10.89B
94K%
31.9
$10.25B
88K%
6.8
Industry: Medical Care Facilities (Global)
Name
Market Cap diff.
PE
$232.18B
852.82B AED
2M%
44.1
$26.55B
22.97B EUR
229K%
15.0
$25.45B
22.02B EUR
220K%
24.9
$22.48B
84.42B SAR
194K%
35.2
$19.14B
77.85B MYR
165K%
37.0
$16.69B
84.79B BRL
144K%
18.1
chevron_leftBack